Document Detail


alpha-Melanocyte-stimulating hormone during human perinatal life.
MedLine Citation:
PMID:  8392079     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To obtain information on human pituitary intermediate lobe activity throughout the perinatal period, plasma alpha MSH immunoreactivity (IR) was measured in 106 newborns at delivery and during the first week of postnatal life. Subjects were divided into groups according to gestational age at birth, mode of parturition, and antenatal state of health. Plasma alpha MSH IR decreased progressively from severe preterm to fullterm neonates born by vaginal delivery (VD; P < 0.001) or cesarean section (CS) with and without prenatal distress (P < or = 0.001 in both cases). alpha MSH IR was due, in all studied conditions, to three major forms: desacetyl alpha MSH, alpha MSH, and diacetyl alpha MSH. Desacetyl alpha MSH was always the most represented form, but it decreased from 75-80% of the total in severe premature to 40-45% in mature infants. In term neonates, total alpha MSH IR values were higher in subjects born by normal VD than by elective CS (P < or = 0.05), in complicated than in normal VD (P < or = 0.01), and in CS performed because of fetal distress than in elective CS (P < or = 0.01). No significant difference was detectable in mature subjects in the percentages of the three alpha MSH forms in relation to the mode of delivery and fetal state during antenatal life or at parturition. Twelve hours after birth, total alpha MSH IR significantly decreased in all groups of term newborns, reaching a plateau of 0.8-1.4 pmol/L. In premature infants, similar concentrations were detectable by the fourth postnatal day. We conclude that 1) alpha MSH IR intermediate lobe secretion progressively decreases throughout the third trimester of pregnancy; 2) stress, including that pertinent to parturition, stimulates alpha MSH IR release; and 3) pituitary intermediate lobe activity declines shortly after birth independently of the maturity reached by the fetus, the mode of parturition, and the presence of antenatal chronic distress, although the process is slightly retarded in premature newborns.
Authors:
A Mauri; A Volpe; M C Martellotta; V Barra; U Piu; G Angioni; S Angioni; A Argiolas
Related Documents :
1377389 - Maternal serum alpha-fetoprotein levels and fetal outcome in early second-trimester oli...
9664599 - Neural-tube defects are associated with low concentrations of cobalamin (vitamin b12) i...
1692399 - Evaluation of elevations in maternal serum alpha-fetoprotein: a review.
2476929 - The role of ultrasonography and amniocentesis in the evaluation of pregnancies at risk ...
12868089 - Very low alpha-fetoprotein in down syndrome maternal serum screening.
19567449 - Role of micronutrients in the periconceptional period.
24145309 - Early predictors of gestational hypertension in a low-risk cohort. results of a pilot s...
8260059 - Can magnesium sulfate therapy impact lactogenesis?
2399969 - Protein content and myosin light chain phosphorylation in uterine arteries during pregn...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  77     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1993 Jul 
Date Detail:
Created Date:  1993-08-06     Completed Date:  1993-08-06     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  113-7     Citation Subset:  AIM; IM    
Affiliation:
Institute of Obstetrics and Gynecology, University of Cagliari, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cesarean Section
Chromatography, High Pressure Liquid
Delivery, Obstetric
Fetal Distress / blood
Gestational Age
Health Status
Humans
Infant, Newborn
Infant, Premature / blood*
Pituitary Gland / physiology
alpha-MSH / blood*,  isolation & purification
Chemical
Reg. No./Substance:
581-05-5/alpha-MSH

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The antiemetic efficacy and safety of granisetron compared with metoclopramide plus dexamethasone in...
Next Document:  Transport and metabolism of iodothyronines in cultured human hepatocytes.